Institutionelle bei Abgenix

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Taunus Corporation 3,341,821 $26,567,476
JP Morgan Chase & Company 3,034,557 $24,124,728
Price (T.Rowe) Associates 2,997,269 $23,828,288
Franklin Resources, Inc 2,889,950 $22,975,102
Orbimed Advisors Inc. 2,826,500 $22,470,675
Wellington Management Company 1,963,800 $15,612,210
Deerfield Management 1,930,000 $15,343,500
Pequot Capital Management, Inc. 1,843,000 $14,651,850
FMR Corporation (Fidelity Management & Research Corp) 12,918,402 $102,701,295
Brinson Partners, Inc. 1,687,650 $13,416,817

Topliste der investierten Fonds
Fidelity Growth Company Fund 4,406,200 $35,029,290
Fidelity Aggressive Growth Fund 2,199,500 $17,486,025
Fidelity Select Portfolios - Biotechnology 1,974,100 $15,694,095
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 1,606,960 $12,775,332
Eaton Vance Global Health Portfolio 1,600,000 $12,720,000
Franklin Strategic Series-Franklin Small-Mid Cap Growth Fd 1,181,000 $9,388,950
Variable Insurance Products Fd-Growth Portfolio 1,181,842 $9,395,643
Finex Fonds Bio Spezial 1,100,000 $8,745,000
Fidelity Advisor Equity Growth Fund 1,077,000 $8,562,150
Putnam Vista Fund 1,082,500 $8,605,875